Your browser doesn't support javascript.
loading
The metastatic capacity of high-grade serous ovarian cancer cells changes along disease progression: inhibition by mifepristone.
Ritch, Sabrina J; Noman, Abu Shadat M; Goyeneche, Alicia A; Telleria, Carlos M.
Afiliación
  • Ritch SJ; Experimental Pathology Unit, Department of Pathology, Faculty of Medicine and Health Sciences, McGill University, Montreal, QC, Canada.
  • Noman ASM; Department of Biochemistry and Molecular Biology, Chittagong University, Chittagong, Bangladesh.
  • Goyeneche AA; Experimental Pathology Unit, Department of Pathology, Faculty of Medicine and Health Sciences, McGill University, Montreal, QC, Canada. alicia.goyeneche@mcgill.ca.
  • Telleria CM; Cancer Research Program, Research Institute, McGill University Health Centre, Montreal, QC, Canada. alicia.goyeneche@mcgill.ca.
Cancer Cell Int ; 22(1): 397, 2022 Dec 09.
Article en En | MEDLINE | ID: mdl-36494669
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Cancer Cell Int Año: 2022 Tipo del documento: Article País de afiliación: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Cancer Cell Int Año: 2022 Tipo del documento: Article País de afiliación: Canadá